
CureVac N.V. CVAC
CureVac N.V. P/B | CVAC
P/B Jährlich CureVac N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.13 | 19.3 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 19.3 | 5.13 | 12.2 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Ionis Pharmaceuticals
IONS
|
26.4 | $ 43.5 | 0.62 % | $ 6.96 B | ||
|
Agios Pharmaceuticals
AGIO
|
1.37 | $ 31.25 | 0.88 % | $ 1.81 B | ||
|
Foghorn Therapeutics
FHTX
|
-3.28 | $ 2.0 | 0.74 % | $ 126 M | ||
|
Inhibikase Therapeutics
IKT
|
0.927 | $ 2.0 | 0.5 % | $ 197 M | ||
|
Kamada Ltd.
KMDA
|
1.29 | $ 8.0 | 1.34 % | $ 461 M | ||
|
Intellia Therapeutics
NTLA
|
1.16 | $ 12.75 | 4.0 % | $ 1.38 B | ||
|
Ultragenyx Pharmaceutical
RARE
|
-27.6 | $ 14.5 | 3.19 % | $ 1.43 B | ||
|
Viridian Therapeutics
VRDN
|
4.14 | $ 19.0 | 2.16 % | $ 1.93 B | ||
|
AbbVie
ABBV
|
2.98 | $ 265.76 | 1.12 % | $ 470 B | ||
|
AbCellera Biologics
ABCL
|
0.995 | $ 13.78 | 0.29 % | $ 4.12 B | ||
|
Abeona Therapeutics
ABEO
|
1.58 | $ 5.11 | 1.59 % | $ 271 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
11.1 | $ 4.67 | 4.94 % | $ 895 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
2.97 | $ 20.11 | 0.8 % | $ 3.39 B | ||
|
Achieve Life Sciences
ACHV
|
5.88 | $ 7.01 | 0.13 % | $ 306 M | ||
|
AC Immune SA
ACIU
|
6.4 | $ 2.71 | 0.55 % | $ 273 M | ||
|
Aclaris Therapeutics
ACRS
|
3.73 | $ 4.27 | 0.79 % | $ 523 M | ||
|
Adagene
ADAG
|
4.32 | $ 2.8 | 0.28 % | $ 165 M | ||
|
ADC Therapeutics SA
ADCT
|
-0.745 | $ 1.23 | 8.85 % | $ 156 M | ||
|
Adial Pharmaceuticals
ADIL
|
0.248 | $ 4.35 | 5.58 % | $ 2.91 M | ||
|
ADMA Biologics
ADMA
|
7.92 | $ 10.11 | 4.01 % | $ 2.41 B | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
11 | $ 29.84 | 5.26 % | $ 4.53 B | ||
|
Agenus
AGEN
|
0.431 | $ 8.73 | 4.43 % | $ 260 M | ||
|
AIM ImmunoTech
AIM
|
-0.116 | $ 0.19 | 5.56 % | $ 308 K | ||
|
Akebia Therapeutics
AKBA
|
10.3 | $ 0.91 | 5.26 % | $ 234 M | ||
|
Akari Therapeutics, Plc
AKTX
|
285 | $ 8.76 | 0.46 % | $ 590 B | ||
|
Aldeyra Therapeutics
ALDX
|
7.38 | $ 0.92 | 4.88 % | $ 55.3 M | ||
|
Alector
ALEC
|
8.07 | $ 1.99 | 9.94 % | $ 205 M | ||
|
Aligos Therapeutics
ALGS
|
1.23 | $ 5.4 | 0.36 % | $ 53.4 M | ||
|
Alkermes plc
ALKS
|
2.82 | $ 42.76 | 2.42 % | $ 7.04 B | ||
|
Allogene Therapeutics
ALLO
|
1.86 | $ 1.5 | 0.33 % | $ 331 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
51.7 | $ 219.89 | 0.08 % | $ 28.8 B | ||
|
Altimmune
ALT
|
1.41 | $ 2.67 | 0.36 % | $ 235 M | ||
|
ALX Oncology Holdings
ALXO
|
4.4 | $ 1.21 | 1.23 % | $ 64.9 M | ||
|
Amgen
AMGN
|
2.19 | $ 402.98 | 0.08 % | $ 217 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 25.37 | 0.39 % | $ 1.19 B | ||
|
Amarin Corporation plc
AMRN
|
12.6 | $ 12.09 | 0.31 % | $ 5.02 B | ||
|
Amneal Pharmaceuticals
AMRX
|
1.17 | $ 20.35 | 0.25 % | $ 6.38 B | ||
|
AnaptysBio
ANAB
|
5.02 | $ 49.2 | 1.38 % | $ 1.43 B | ||
|
Anika Therapeutics
ANIK
|
1.12 | $ 19.73 | 3.3 % | $ 283 M | ||
|
ANI Pharmaceuticals
ANIP
|
2.3 | $ 72.58 | 0.55 % | $ 1.46 B | ||
|
Annexon
ANNX
|
3.63 | $ 4.2 | 0.24 % | $ 651 M | ||
|
Annovis Bio
ANVS
|
3.07 | $ 1.2 | 1.69 % | $ 24.7 M | ||
|
Aprea Therapeutics
APRE
|
0.312 | $ 0.68 | 0.16 % | $ 4.45 M | ||
|
Aptevo Therapeutics
APVO
|
0.0819 | $ 1.8 | 2.27 % | $ 568 K | ||
|
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.57 | 0.44 % | $ 489 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
1.01 | $ 14.66 | 12.51 % | $ 401 M | ||
|
Ardelyx
ARDX
|
9.72 | $ 3.39 | 1.5 % | $ 817 M | ||
|
argenx SE
ARGX
|
5.79 | $ 912.87 | 1.28 % | $ 56 B | ||
|
Armata Pharmaceuticals
ARMP
|
-1.43 | $ 3.66 | 3.98 % | $ 133 M | ||
|
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 25.15 | 0.04 % | $ 3.2 B |